27 June 2025
MicroSalt Plc
("MicroSalt" or the "Company")
Result of AGM
MicroSalt plc, a leading manufacturer of full flavour salt with approximately 50% less sodium is pleased to announce that all resolutions proposed to shareholders at its Annual General Meeting today were duly passed.
The total number of votes received in respect of all resolutions were as follows:
|
| For | Against | Votes Withheld | Total votes cast | |||
| Number of Votes | % | Number of Votes | % | ||||
| Ordinary Resolutions | |||||||
| 1. Approval of Annual Report and Accounts | 34,823,571 | 99.96 | 15,264 | 0.04 | 103 | 34,838,835 | |
| 2. To re-appointment Crowe U.K. LLP as Auditors | 34,822,719 | 99.95 | 15,852 | 0.05 | 367 | 34,838,571 | |
| 3. To authorise Directors to set Auditors remuneration | 34,822,744 | 99.95 | 16,091 | 0.05 | 103 | 34,838,835 | |
| 6. To re-elect Judith Batchelar as a Director | 34,813,092 | 99.94 | 19,163 | 0.06 | 6,683 | 34,832,255 | |
| 4. To re-elect Rick Guiney as a Director | 34,819,303 | 99.94 | 19,163 | 0.06 | 472 | 34,838,466 | |
| 5. To re-elect Konrad Dabrowski as a Director | 34,818,715 | 99.94 | 19,751 | 0.06 | 472 | 34,838,466 | |
| 7. To re-elect Gary Urmston as a Director | 34,820,032 | 99.95 | 18,434 | 0.05 | 472 | 34,838,466 | |
| 8. To re-elect Daniel Emery as a Director | 34,821,246 | 99.95 | 17,220 | 0.05 | 472 | 34,838,466 | |
| 9. Authority to Allot Shares | 34,783,598 | 99.95 | 18,034 | 0.05 | 37,306 | 34,801,632 | |
| Special Resolution | |||||||
| 10. Disapplication of pre-emption rights | 34,788,116 | 99.94 | 19,358 | 0.06 | 31,464 | 34,807,474 | |
Notes:
1. Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.
2. Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".
4. The number of shares in issue on 27 June 2025 was 51,963,276.
5. The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at www.microsalt.co.
For further information, please visit MicroSalt's website or contact:
| MicroSalt plc | Via Flagstaff PR |
| Rick Guiney, CEO | |
| | |
| Zeus (Nominated Adviser and Broker) | +44 (0)20 3829 5000 |
| David Foreman / James Edis (Investment Banking) | |
| Dom King (Corporate Broking), Rupert Woolfenden (Sales) | |
| | |
| Flagstaff PR (Financial PR/IR) | +44 (0)20 7129 1474 |
| Tim Thompson / Alison Allfrey / Anna Probert | |
Notes to Editors
MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70 per cent. of the typical person's sodium intake is hidden in processed foods.
Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market. The group has a US patent and 14 patent applications pending in other jurisdictions globally.
The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.